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A syndrome of motoric and neuropsychiatric symptoms comprising various elements, including chorea, hyperactivity, tics, emotional
lability, and obsessive-compulsive symptoms, can occur in association with group A -hemolytic streptococcal (GABHS) infection. We
tested the hypothesis that an immune response to GABHS can result in behavioral abnormalities. Female SJL/J mice were immunized and
boosted with a GABHS homogenate in Freund’s adjuvant, whereas controls received Freund’s adjuvant alone. When sera from GABHS-
immunized mice were tested for immunoreactivity to mouse brain, a subset was found to be immunoreactive to several brain regions,
including deep cerebellar nuclei (DCN), globus pallidus, and thalamus. GABHS-immunized mice having serum immunoreactivity to DCN
also had increased IgG deposits in DCN and exhibited increased rearing behavior in open-field and hole-board tests compared with
controls and with GABHS-immunized mice lacking serum anti-DCN antibodies. Rearing and ambulatory behavior were correlated with
IgG deposits in the DCN and with serum immunoreactivity to GABHS proteins in Western blot. In addition, serum from a GABHS mouse
reacted with normal mouse cerebellum in nondenaturing Western blots and immunoprecipitated C4 complement protein and -2-
macroglobulin. These results are consistent with the hypothesis that immune response to GABHS can result in motoric and behavioral
disturbances and suggest that anti-GABHS antibodies cross-reactive with brain components may play a role in their pathophysiology.
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Introduction
Group A -hemolytic streptococcal (GABHS) infection is asso-
ciated with a spectrum of neurologic and neuropsychiatric disor-
ders, including Sydenham’s chorea (SC), obsessive-compulsive
disorder (OCD), Tourette sydrome (TS), chronic tic disorder
(CTD), and attention-deficit/hyperactivity disorder (ADHD)
(Husby et al., 1977; Swedo et al., 1998; Peterson et al., 2000;
Muller et al., 2001). There is considerable diagnostic comorbidity
among these disorders. A common theme is the concept that
dysfunctions in the cortico-striato-thalamo-cortical (CSTC) cir-
cuits normally implicated in the integration of emotional, cogni-
tive, and motor functions contribute to their pathogenesis. Volu-
metric or metabolic abnormalities in the orbital frontal cortex,
anterior cingulate cortex, thalamus, caudate, putamen, and glo-
bus pallidus have been reported in subjects with SC, OCD, TS,
CTD, and ADHD (Sheppard et al., 1999) and decreased volumes
of posterior cerebellar vermis were reported in subjects with
ADHD (Mostofsky et al., 1998; Castellanos et al., 2001).
SC is a variant of rheumatic fever (RF) attributed to serum
anti-GABHS antibodies that cross-react with neurons in the basal
ganglia (Husby et al., 1977). OCD, ADHD, tic disorders, emo-
tional lability, hyperactivity, and age-regressed behavior fre-
quently accompany SC (Swedo et al., 1989, 1993; Moore, 1996;
Asbahr et al., 1998; Mercadante et al., 2000). Swedo et al. (1998)
characterized a subgroup of pediatric subjects with OCD or tic
disorders without comorbid SC, the symptom onset of which was
associated with GABHS infection; this subgroup was designated
with the acronym PANDAS (Pediatric Autoimmune Neuropsy-
chiatric Disorders Associated with Streptococcal Infection).
Many PANDAS subjects had comorbid ADHD, affective disor-
der, and anxiety disorders.
Altered immune processes may play a role in the onset or
exacerbation of neuropsychiatric symptoms associated with
GABHS infection. Increased serum anti-GABHS antibody titers
were associated with a diagnosis of ADHD. In addition, elevated
anti-GABHS antibody titers predicted increased putamen and
globus pallidus volumes measured with magnetic resonance im-
aging (MRI) in subjects with ADHD and OCD (Peterson et al.,
2000). In PANDAS subjects, increased caudate, putamen, and
globus pallidus volumes were interpreted to represent localized
brain inflammation (Giedd et al., 2000). An increased proportion
of B lymphocytes of PANDAS subjects was positive for the anti-
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gen D8/17, a marker associated with vulnerability to RF (Swedo
et al., 1997). Immune-modulating therapies [intravenous Ig
(IVIg) and plasmapheresis] ameliorated neuropsychiatric symp-
toms in PANDAS (Perlmutter et al., 1999). Last, pediatric sub-
jects with OCD had elevated levels of type-1 cytokines in CSF
compared with subjects with schizophrenia (Mittleman et al.,
1997). These findings are consistent with models wherein
GABHS infection or abnormal immune functions are factors in
the pathogenesis of a subset of OCD, tic disorders, or ADHD, or
where common underlying genetic factors underlie vulnerability
to both neuropsychiatric disorders and GABHS infections.
To investigate the mechanisms by which immune response to
GABHS antigens might alter neuronal function and cause behav-
ioral disturbances, we established a murine model on the basis of
experimental immunization with a homogenate prepared from
GABHS. Experiments reported here test the hypothesis that an
immune response to GABHS can lead to behavioral abnormali-
ties reminiscent of those reported in PANDAS.
Materials and Methods
GABHS homogenate (immunogen)
Blood agar plates were inoculated with Streptococcus pyogenes, group A
type 6 (12348; American Type Culture Collection, Manassas, VA), and
incubated overnight at 37°C. Brain-heart infusion broth (Difco, Kansas
City, MO) was inoculated with colonies that displayed clear -hemolytic
activity on blood agar. After incubation at 37°C for 96 hr, bacteria were
collected by centrifugation and resuspended in sterile PBS. To prepare
GABHS homogenate, bacteria were pelleted, rinsed with PBS, pelleted
again, and resuspended in water. Zirconia–silica beads (0.1 mm; BioSpec
Products, Bartlesville, OK) were added, and the suspension was vortexed
for 12 min at 4°C. Supernatant was collected after the beads settled out of
the suspension. Beads were rinsed with water, and rinse water was added
to the supernatant. After beads were removed from the supernatant by
centrifugation at 6000 rpm, the supernatant (hereafter designated
GABHS homogenate) was collected and stored at 70°C. GABHS ho-
mogenate was incubated with blood agar plates to verify that it contained
no viable bacteria.
Animals and immunization protocol
All housing, care, experimental procedures, and killing of mice were
performed according to Association for Assessment and Accreditation of
Laboratory Animal Care guidelines and approved by the Institutional
Animal Care and Use Committee at University of California Irvine be-
fore initiation. Five-week-old female SJL/J mice (The Jackson Labora-
tory, Bar Harbor, ME) were housed under fluorescent lighting set to a 12
hr light/dark schedule. Primary immunization was performed when the
mice were 6 weeks of age. Complete Freund’s adjuvant (CFA) and in-
complete Freund’s adjuvant (IFA) were obtained from Sigma-Aldrich
(St. Louis, MO). Each mouse in the GABHS group was immunized sub-
cutaneously with125l of 1:1 emulsion of CFA:PBS containing 2.5l
of GABHS homogenate. Control mice were immunized with125l of
CFA:PBS alone. Boosts were given at 4 or 6 week intervals and consisted
of 125 l of 1:1 emulsion of IFA:PBS containing 2.5 l of GABHS
homogenate (for GABHS mice) or 125 l of IFA:PBS alone (control
mice). Blood (50 –350 l) was collected by tail bleed 14 d after the
primary immunization and after each boost. After clotting and centrifu-
gation at low speed, serum was collected and stored at 70°C. Animals
examined for brain IgG deposits were killed 3 weeks after the third boost.
Two sets of mice were immunized. The first set (n 7 GABHS; n 7
controls) was immunized at 6 weeks of age and then boosted three times
at 6 week intervals. The second set (n 16 GABHS; n 13 controls) was
immunized at 6 weeks of age and boosted three times at 4 week intervals.
Sera were collected 2 weeks after each boost. Sera from boosts 1, 2, and 3
were screened for immunoreactivity to brain tissue.
Behavioral testing
An automated system (Tru Scan testing arenas and Tru Scan 99 software;
Coulbourn Instruments, Allentown, PA) was used to quantitate move
time (total time in movement), distance (sum of vectored coordinate
displacements), ambulatory distance (measurement of locomotion),
center time (time in center of arena), dark time (time in a darkened
plastic box, having a small hole for entry and exit that was placed in the
arena), rearing count (the number of times the mouse stands upright),
and exploratory nose pokes into a hole board (total number of times the
mouse inserts its snout into holes cut into the false floor of a hole board).
Behavior was tested during two trials. Trial 1 began 2 d after the boost
2 blood draw, and trial 2 began 4 d after boost 3 blood draw. For each
trial, three different behavioral tests were performed in the following
sequence: dark box, open field, and hole board. The dark-box test was
used to assess anxiety behavior, in which increased preference for the
darkened half of an open field indicated increased anxiety. Open-field
test provided an overall indication of behavioral response to a novel open
environment (e.g., behavioral inhibition or activation when confronted
with unfamiliar surroundings) and exploratory strategies (e.g., ambula-
tory distance, center time, rearing). The number of nose pokes into a hole
board reflected exploratory behavior.
On the morning of the test (8:00 to 10:00 A.M.), mice were moved
from the vivarium to a separate behavioral testing room, where they
remained until the testing for that day was complete. Tests were per-
formed from 1:00 to 6:00 P.M. The dark-box test was administered first
(2 or 4 d after blood draw for trial 1 or trial 2, respectively), followed by
the open-field test (3 or 2 d after dark box for trial 1 or trial 2, respec-
tively) and the hole-board test (2 or 1 d after open field for trial 1 or trial
2, respectively). The testing arena was illuminated with a 75 watt incan-
descent bulb affixed 18 inches above the floor of the arena. Pairs of
mice (1 control, 1 GABHS) were tested simultaneously in separate are-
nas. Before placement in testing arenas, individual mice were placed into
a 500 ml glass beaker for 1 min to ensure a similar state of behavioral
activation. For dark-box tests, mice were placed in the lit side of the
arena, near the opening to the dark box. For open-field tests, mice were
placed in the center of the arena. For hole-board tests, mice were placed
in one of the corners, facing the walls. Test recording began immediately
after the mouse was placed in the arena. The duration of the dark-box test
was 5 min; the open-field and hole-board tests were 10 min each.
Immunohistochemistry
IgG and CD45. Mice were anesthetized with CO2 and then decapitated.
Brains were placed into ice-cold PBS, sectioned in the coronal plane at 3
mm intervals, and immersed overnight in 30% sucrose/PBS at 4°C. Brain
slices were then quick frozen at 20°C in Tissue-Tek OCT compound
(Sakura Finetek, Torrance, CA). Cryostat sections (14M) were air-dried
onto slides at 37°C. Horseradish peroxidase (HRP)-conjugated goat anti-
mouse IgG was obtained from Sigma-Aldrich. Biotin-conjugated rat
anti-mouse CD45 antibody was obtained from PharMingen (San Diego,
CA). Sections on slides were fixed in 4% paraformaldehyde/PBS at room
temperature for 6 min (mouse sera immunolabeling and visualization of
IgG deposits in the brain) or 20 min (CD45 immunolabeling) and then
rinsed 5 min in PBS. After fixation, sections to be immunolabeled with
mouse sera were preincubated for 30 min in immunobuffer (4  con-
centrated PBS, containing 10% FBS), followed by overnight incubation
in the primary antibody solution (1:200 dilution of mouse serum in
immunobuffer) at 4°C. After rinsing for 30 min in immunobuffer, sec-
tions were incubated for 4 hr in immunobuffer containing secondary
antibody (HRP-conjugated goat anti-mouse IgG). Sections were rinsed
for 30 min in immunobuffer, developed with diaminobenzidine (DAB)
solution (Vector Laboratories, Burlingame, CA), dehydrated in ethanol,
cleared with Americlear clearing solvent (Allegiance Healthcare, McGaw
Park, IL), and mounted in Permount (Fisher Scientific, Pittsburgh, PA).
For visualization of IgG deposits, fixed sections were incubated in HRP-
conjugated goat anti-mouse IgG (1:300, in immunobuffer) overnight at
4°C. The following day, sections were rinsed and developed as described
above. For anti-CD45 immunolabeling, fixed sections were immersed in
95°C citrate buffer, microwaved for 30 sec, and allowed to remain in
the hot buffer for 2 min. The sections were then incubated in immu-
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nobuffer containing 0.01% detergent (Triton X-100) for 1 hr, rinsed 15
min in PBS, and incubated in biotin-conjugated rat anti-mouse
CD45overnight at 4°C. The following day, slides were rinsed with
immunobuffer and developed with Vector Elite ABC kit and DAB
solution (Vector Laboratories).
To determine significant correlations between IgG deposits in the deep
cerebellar nuclei (DCN) and behavioral phenotype, cerebellar sections
from the 10 control and 10 GABHS that underwent behavioral testing
were immunolabeled for detection of IgG deposits. The slides were coded
for blinded analysis and ranked in ascending order from least (having a
rank score of 1) to greatest (having a rank score of 20) anti-IgG immu-
nolabeling in the DCN. For rank scoring of IgG deposits in the DCN, IgG
immunolabeling in the central portion of the anterior interposed nucleus
was examined, except in one case in which this region was not present in
the section; in this case, the posterior interposed nucleus was examined.
GABHS antisera and synaptosomal associated protein of 25 kDa. CO2-
anesthetized normal adult female SJL mice were perfused through the left
ventricle using ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer,
pH 7.4. Brains were removed, postfixed in the same solution overnight at
4°C and cryoprotected in 30% sucrose/PBS for 36 hr at 4°C. Cryostat
sections (14 M) were collected on slides, permeabilized with 0.1% Tri-
ton X-100 for 30 min, and then blocked for 1 hr in PBS with 10% normal
goat serum (NGS; Sigma). Sections were incubated overnight with con-
trol or GABHS mouse sera diluted 1:200 with 1% NGS in PBS. Rabbit
polyclonal antisera to synaptosomal associated protein of 25 kDa (SNAP-
25) (1:500; gift from Michael Wilson, University of New Mexico, Albu-
querque, NM) was used as a synaptic marker; preimmune rabbit sera was
used as a control. Sections were incubated for 30 min with secondary
antibodies [goat anti-mouse and rabbit IgG tetramethylrhodamine iso-
thiocyanate (TRITC)/FITC, 1:200 in PBS]. The sections were dehydrated
serially in increasing concentrations of ethanol, incubated for 20 min
with Hoechst nuclear stain (Sigma) diluted in 95% ethanol, and then
mounted with Permount (Fisher Scientific). Images were captured with a
Nikon (Tokyo, Japan) E600 microscope with Nikon Spot software.
Preabsorption of anti-brain immunoreactivity with GABHS homoge-
nate. A 1:200 dilution of mouse immune serum in 250 l of immu-
nobuffer was incubated in suspension with 80l of GABHS homogenate
overnight at 4°C in a tumbler. After pelleting of homogenate by centrif-
ugation, the supernatant (antibody solution) was used immediately for
immunohistochemistry. As a control for specificity of the preabsorption
effect, a separate aliquot of each mouse immune serum was treated sim-
ilarly (dilution, overnight tumbling at 4°C, centrifugation) with the ex-
ception of incubation with homogenate.
Reactivity of mouse sera to Western blotted GABHS proteins
To prepare GABHS protein extract, GABHS homogenate was diluted 1:1
in 0.2 M Tris, pH 6.8, containing 4% SDS, incubated at 100°C for 10 min,
and centrifuged at 15,000 rpm for 15 min to pellet the insoluble material.
The resulting supernatant (GABHS extract) was collected and stored at
70°C. Proteins in GABHS extract were fractionated by SDS-PAGE
(Laemmli and Favre, 1973) and transferred to nitrocellulose using a
semidry blotting apparatus.
To determine the immunoreactivity of individual mouse sera to blot-
ted GABHS proteins, strips were cut from GABHS protein blot and in-
cubated for 30 min in blocking buffer [Tris-buffered saline containing
0.05% Tween 20 (detergent) and 0.5% dried milk powder] at room tem-
perature. The strips were then placed in individual wells, each containing
diluted serum from a single mouse. Sera collected from mice 2 d before
trial 1 behavioral tests were diluted to 1:250 or 1:2500 with blocking
buffer. Strips were incubated overnight at 4°C and then rinsed the fol-
lowing day at room temperature for 30 min, with three changes of Tris-
buffered saline containing 0.05% Tween 20. The strips were incubated
for 4 hr at room temperature in secondary antibody solution (HRP-
conjugated goat anti-mouse IgG, 1:1000 in blocking buffer). The strips
were again rinsed as above and developed with Immunopure 3,3,5,5
tetramethylbenzidine (TMB) (Pierce, Rockford, IL) solution (3 mg/ml
Immunopure TMB in EtOH, diluted 1:10 in Tris-buffered saline, with
0.1% H2O2). GABHS polypeptides to which sera were immunoreactive
were visible on the GABHS Western blot as blue bands. For strips incu-
bated in serum diluted to 1:2500, the number of bands visible on each
strip was counted and provided a quantitative measure (the anti-GABHS
immunoreactivity index) of serum immunoreactivity to GABHS
polypeptides. The anti-GABHS immunoreactivity index was used to test
for correlations between serum anti-GABHS antibody response and spe-
cific behavioral variables.
Nondenaturing Western blots and immunoprecipitation
Normal SJL mouse frontal cortex, striatum, and cerebellum were dis-
sected and then homogenized with a Dounce tissue homogenizer
(Wheaton Scientific, Millville, NJ) in PBS. Five micrograms of homoge-
nate was resuspended in native protein-loading buffer (10% glycerol, 0.1
M Tris, pH 6.8, bromophenol blue). Proteins were size-fractionated by
PAGE in a 10 or 12% gel and then transferred to nitrocellulose membranes
(Bio-Rad, Hercules, CA). Membranes were blocked with 10% nonfat milk in
PBS for 1 hr and then incubated for 1 hr with immune sera of a single mouse
(diluted 1:500 with 1% nonfat milk in PBS). After washing with 0.1% Tween
20 in PBS, the membranes were incubated with HRP-conjugated, rabbit
anti-mouse IgG as secondary antibody (Bio-Rad), diluted 1:2000 in 1% non-
fat milk in PBS. Antibody binding was visualized with ECL Plus Western
blotting detection reagent (Amersham Biosciences, Arlington Heights, IL).
Immunoprecipitations (IPs) were pursued under nondenaturing con-
ditions. Because of the uncertainty of the antibody isotype, protein A and
protein G beads (Sigma) were both used for precipitation in a buffer
composed of 25 mM HEPES, 137 mM NaCl, 1 mM MgCl2, 1% Triton
X-100, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluo-
ride, 50 mM sodium fluoride, 10 g/ml aprotinin, and 10 g/ml leupep-
tin (IP buffer). All procedures were conducted on ice; incubations at 4°C
were continuously mixed by rotation. Mouse immunoglobulins were
bound to 50 l of protein A–G by incubation in IP buffer for 1 hr. The
beads were then added to 1 mg of brain homogenates, resuspended in
buffer, and incubated for 1 hr. Ten microliters of normal mouse sera or
GABHS sera was added to precleared supernatant and incubated over-
night. Fifty microliters of fresh protein A–G beads was added to the
supernatant and incubated for 4 hr. Beads were washed five times with 1
ml of IP buffer. Twenty microliters of SDS-loading buffer was added to
the beads, and proteins were eluted by boiling for 5 min. Proteins were
size-fractionated by 10% SDS-PAGE and visualized by incubation with
50 ml of SYPRO Ruby Protein gel stain overnight (Molecular Probes,
Eugene, OR). Unique bands were excised and subjected to liquid chro-
matography/mass spectrometry/mass spectrometry (LC/MS/MS) analy-
sis. Briefly, gel fragments were digested with endoproteinase Lys-C and
trypsin (Roche Molecular Biochemicals, Indianapolis, IN). Peptides were
extracted with 50% acetonitrile/2% trifluoroacetic acid and then reduced
in volume to 10l. Mass spectrometry was performed with a Micromass
Q-Tof hybrid quadruple/time of flight mass spectrometer with a nano-
electrospray source. The processed files were submitted to a MASCOT
search (Matrix Science, London, UK).
Statistical analysis
Categorical data were analyzed using  2 test (Glass and Hopkins, 1996).
Statview v.5.0.1 software (SAS Institute, Cary, NC) was used for all other
statistical analyses. Group comparisons were done using ANOVA; when
appropriate, Fisher’s PLSD was used for post hoc comparisons. Kruskal–
Wallis and Mann–Whitney U tests were used for nonparametric group
comparisons. Correlational analyses were done using Z test followed by
Fisher’s r to z transformation (parametric) or Spearman rank correlation
(nonparametric). For all tests, statistical significance was assumed where
p 0.05.
Results
Anti-brain immunoreactivity of sera from GABHS- and
control-immunized mice
Sera obtained from GABHS mice were screened for the presence
of brain cross-reactive antibodies by immunoperoxidase and in-
1782 • J. Neurosci., February 18, 2004 • 24(7):1780 –1791 Hoffman et al. • Streptococcal Infection and Neuropsychiatric Disorders
direct immunofluorescence microscopy using sections of nor-
malSJL mouse brain. GABHS mouse serum labeled cell bodies of
neurons in DCN. Control sera obtained from mice treated with
CFA:IFA did not react with sections of brain tissue. Double-
labeling experiments using GABHS immune sera and antibodies
to the synaptic marker SNAP-25 revealed colocalization in DCN
(Fig. 1). Immunoreactivity to the DCN was first detected in se-
rum collected after the second boost. Sera were less intensely
immunoreactive to several other brain regions including lat-
eral hypothalamus, globus pallidus, reticular thalamic nu-
cleus, superior and inferior colliculus, deep mesencephalic
nuclei, pontine nuclei, tegmental nuclei, periolivary nucleus,
and several other brainstem motor and sensory nuclei (data
not shown).
To assess whether anti-DCN immunoreactivity in GABHS
mice was attributable to cross-reactivity with GABHS epitopes
present in the original immunogen, sera were preabsorbed with
GABHS homogenate before application to tissue sections. Preab-
sorption of GABHS sera with GABHS homogenate removed the
majority of the punctate anti-DCN immunoreactivity (Fig. 2).
Control sera immunoreactivity to DCN was not preabsorbed
by GABHS homogenate.
IgG deposits in the brain of GABHS mice
The presence of IgG deposits in the DCN of control (n 10) and
GABHS (n  10) mice was assessed by anti-IgG immunohisto-
chemistry. In GABHS mice, anti-IgG immunolabeling in DCN
(Fig. 3) was intense in regions adjacent to capillaries. In many
areas, anti-IgG label was punctate. In the control mice, anti-IgG
label was less pronounced and appeared to be contained within
blood vessels (Fig. 3b).
To determine the relationship between GABHS immuniza-
tion, serum anti-DCN antibodies, and IgG deposits in the DCN,
brain tissue sections immunolabeled with
anti-IgG were examined by an observer
blind to experimental treatment. A rank
score (ranging from 1 to 20) was assigned
according to the intensity of DCN anti-
IgG immunoreactivity, providing a quan-
titative measure of IgG deposits in the
DCN. Mann–Whitney U tests showed a
significant effect of GABHS immunization
on rank score for IgG deposits in the DCN
( p  0.0032; mean rank scores: GABHS,
14.4; control, 6.6). The GABHS group was
split into subgroups on the basis of the
presence [anti-DCN(), n  6] or ab-
sence [anti-DCN(), n  4] of serum
anti-DCN antibodies. Comparison of
these two subgroups to controls using the
Kruskal–Wallis test showed a significant
effect of group on rank score for IgG de-
posits in the DCN [p  0.006; mean rank
scores for IgG deposits: serum anti-
DCN(), 16.2; serum anti-DCN(),
11.7; control, 6.6]. Rank scores for IgG de-
posits were significantly greater in serum
anti-DCN() group compared with con-
trol [Mann–Whitney U test; p  0.0024;
mean rank scores for IgG deposits: serum
anti-DCN(), 13.2; control, 5.7]. Rank
scores for IgG deposits in serum anti-
DCN() mice were intermediate to con-
trol and serum anti-DCN() groups and did not differ signifi-
cantly from either control or serum anti-DCN() groups
(Mann–Whitney U test; data not shown). These results indicate
that IgG deposits in the DCN are associated with GABHS immu-
nization and suggest that serum anti-DCN antibodies may be
associated with increased IgG deposits in the DCN.
To determine whether the presence of IgG reflected transfer
from the vascular compartment or local synthesis, sections were
next examined using anti-CD45 antisera for detection of lym-
phocytes. CD45 cell labeling in the cerebellum was similar in
GABHS and control mice. Furthermore, CD45 labeling in
GABHS mice did not vary as a function of the presence of paren-
chymal IgG deposits or the strength of signal associated with
these deposits. Together, these results support the hypothesis that
immunization with GABHS can lead to the production of cross-
reactive antibodies that bind to brain in vivo.
Behavioral analysis of GABHS mice
GABHS (n  10) and control (n  10) mice did not differ in
assays of dark-box time, center time, rearing, or total nose pokes
in either trial 1 (Fig. 4) or trial 2 (data not shown). However,
GABHS mice showed decreased ambulation during the trial 1
open-field test (ANOVA; F  5.338; p  0.0329) (Fig. 4c), but
correction for the multiple comparisons performed across
groups for variables in the open-field test (center time and rear-
ing counts in addition to ambulatory distance) showed these dif-
ferences to no longer be significant (Bonferonni/Dunn; p ns).
These differences in open-field ambulation were not present in
trial 2, and repeated measures ANOVA did not support a signif-
icant effect of group on ambulatory distance across trials 1 and 2
Figure 1. GABHS mouse sera binds specifically to cells in the DCN and colocalizes with the synaptic marker SNAP-25. a, GABHS
mouse serum (TRITC) at 40. b, Rabbit anti-SNAP-25 (FITC) at 40. c, Combined FITC and TRITC image, punctate SNAP25
staining localizes to GABHS mouse sera reactive cell bodies. d, Hematoxylin and eosin at 10. e, Normal mouse sera at 40. Scale
bars, 100m.
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for any of the behavioral tests. It is possible that the decreased
ambulation observed in GABHS mice during trial 1 open field
was attributable to behavioral inhibition in response to novel
surroundings. In support of this hypothesis, the mean ambula-
tory distance for all three behavioral tests was increased in all
groups in trial 2 compared with trial 1. These data are also con-
sistent with the alternative explanation that there were differ-
ences in cytokine-associated, postimmunization sickness behav-
ior, given the shorter 2 d interval between boost 2 and trial 1
testing, as compared with the 4 d interval between boost 3 and
trial 2 testing. Repeated measures ANOVA showed significant
effects of trial on ambulatory distance across trials 1 and 2 for the
dark box (F 4.778; p 0.0431) and hole board (F 8.661; p
0.0096) tests. A trend toward an effect of trial on ambulatory
distance (F 3.098; p 0.0954) was observed across trials 1 and
2 open-field tests. However, there were no significant group 
trial interaction effects on ambulatory distance for any of the
three behavioral tests.
To investigate whether behavioral abnormalities were associ-
ated with the presence of serum anti-DCN IgG, the GABHS
group was split into anti-DCN() and anti-DCN() subgroups
(n  6 and n  4, respectively). ANOVA revealed significant
effects of group on rearing count in trial 1 during the open-field
test (F 5.153; p 0.0178) and hole-board test (F 7.731; p
0.0045). A trend toward an effect of group on rearing count was
observed in trial 1 dark-box test (F 3.051; p 0.0737). Post hoc
Fisher’s PLSD confirmed the significantly increased rearing be-
havior in the anti-DCN() group compared with both the con-
trol and anti-DCN() groups in trial 1 open-field and hole-
board tests (Fig. 5). No group differences were observed in the
time spent in dark box or in the total number of nose pokes into
the hole board. Repeated measures ANOVA showed a significant
effect of group on rearing count across trial 1 and 2 open-field
tests (F 4.674; p 0.0241). Post hoc Fisher’s PLSD confirmed
increased rearing in the anti-DCN() group compared with
both the control ( p  0.0042) and anti-DCN() ( p  0.0014)
groups. Significant effects of group on rearing count were also
present across trial 1 and 2 dark-box (F 4.450; p 0.0279) and
hole-board (F  7.378; p  0.0054) tests. Fisher’s PLSD con-
firmed the significantly increased rearing count across trials 1 and
2 in anti-DCN() group compared with control (dark box, p
0.0039; hole board, p  0.0019) and with anti-DCN() groups
(dark box, p  0.0016; hole board, p  0.0001). There was a
significant effect of trial on rearing count in the dark-box test
(F 10.924; p 0.0042), with decreased rearing count in trial 2
compared with trial 1. Rearing count did not vary between trials
for open-field or hole-board tests, nor were there significant
group trial effects on rearing count in any of the tests.
When control, anti-DCN(), and anti-DCN() groups were
compared using ANOVA, there were no significant effects of
group on ambulatory distance or center time for trial 1 open-field
and hole-board tests. These observations suggested that rearing
count increased independently of ambulatory distance and cen-
ter time in anti-DCN() mice and were consistent with in-
creased rearing behavior reflecting repetitive or compulsive-like
behavior.
Rearing behavior of control mice did not differ with serum
immunoreactivity to DCN. For trial 1 open-field test, the mean
rearing counts for control mice having and lacking serum immu-
noreactivity to DCN were 59 10 and 52 46 SD, respectively.
For comparison, the mean rearing count for GABHS immunized
mice having serum anti-DCN immunoreactivity was 98 25 SD.
Correlates of rearing behavior in GABHS and control mice
Significant correlations between rearing behavior and other be-
havioral variables were assessed in GABHS and control mice us-
ing a Z test followed by Fisher’s r to z transformation. Rearing
count in both control and GABHS mice was highly correlated
with center time in the open-field test and with ambulatory dis-
tance in all three tests (Table 1). There were no correlations be-
tween rearing count and either dark-box time or total number of
nose pokes into the hole board. The observation that rearing
count was positively correlated with ambulatory distance and
center time, but not with dark-box time or nose pokes, is consis-
tent with rearing behavior as a component of ambulation in a
Figure 2. Anti-DCN immunoreactivity can be preabsorbed by incubation with GABHS ho-
mogenate. Diluted GABHS-immune serum (1:200) was either applied to tissue without previous
preabsorption or preincubated with GABHS homogenate before application to tissue sections.
Serum anti-DCN immunoreactivity was visualized with DAB as described in Materials and Meth-
ods. Preabsorption with GABHS homogenate significantly reduced anti-DCN immunoreactivity.
a, DCN tissue incubated in serum from a GABHS mouse. Arrows denote several punctate, immu-
nolabeled structures. b, DCN tissue incubated with GABHS-preabsorbed serum from the same
GABHS mouse. Scale bar, 50m.
Figure 3. Parenchymal and pericapillary IgG deposition is increased in the DCN of GABHS
mice having serum anti-DCN immunoreactivity. Tissue sections from DCN of GABHS and control
mice were incubated in peroxidase-conjugated anti-mouse IgG. Anti-IgG binding to DCN was
visualized using DAB. Anti-IgG immunoreactivity was increased in the DCN parenchyma of
GABHS mice previously determined to have serum anti-DCN immunoreactivity. a, Section from
the DCN of a GABHS-immune mouse that had serum anti-DCN immunoreactivity. Arrowheads
mark the top boundary of a single capillary. Anti-IgG immunoreactivity was particularly intense
in pericapillary areas and was in a punctate pattern (arrows). b, Section from the DCN of a control
mouse. Arrowheads mark the top boundary of a single capillary similar to the one shown in a.
Note the relative lack of pericapillary immunostaining and the absence of punctate immuno-
staining compared with a. Scale bar, 50m.
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novel open space (reflecting spatial orientation behavior), rather
than anxiety or general exploratory behavior.
Behavioral correlates of brain IgG deposits in GABHS and
control mice
We reasoned that if cross-reactive anti-GABHS antibodies al-
tered behavior by binding to brain targets, rearing and ambula-
tion measurements might be correlated with IgG deposits in
brain. To test this hypothesis, raw behavioral data were converted
to ranked data. Spearman’s rank correlation test was used to test
for correlation between the rank scores of DCN IgG deposits and
behavioral measurements. When control and GABHS mice were
analyzed together (n 20), a significant correlation was observed
between the rank scores of DCN IgG deposits and rearing count
(Spearman’s Rho, 0.477; p  0.0377) (Fig. 6). Rank scores for
DCN IgG deposits and ambulatory distance were not correlated.
However, when control and GABHS mice were analyzed sepa-
rately, rank scores for DCN IgG deposits in GABHS mice (n 
10) were significantly correlated with both rearing count (Spear-
man’s Rho, 0.700; p 0.0360) and ambulatory distance (Spear-
man’s Rho, 0.721; p 0.0305). In contrast, for control mice (n
10), rank scores for DCN IgG deposits were not correlated with
either rearing count (Spearman’s Rho, 0.006; p  0.9855) or
ambulatory distance (Spearman’s Rho, 0.455; p 0.1727).
Behavioral correlates of serum antibody responses to
GABHS immunization
To assess whether behavioral disturbances in our mouse model
were correlated with immunity to specific bacterial proteins, we
Figure 4. Open-field ambulation of GABHS mice is decreased compared with control. Behav-
iors during dark-box, open-field, and hole-board tests are shown. a, Time spent in darkened half
of arena during dark-box test. b, Rearing count in open field. c, Ambulatory distance in open
field. d, Total number of exploratory nose pokes into a hole board. Ambulatory distance was
significantly decreased in the GABHS-immunized group compared with control (ANOVA; F
5.338; *p 0.0329). Error bars indicate SE.
Figure 5. Rearing behavior is increased in GABHS-immunized mice having serum immuno-
reactivity to DCN. a–c, Rearing count during dark-box test ( a), open-field test ( b), and hole-
board test ( c) for trial 1. Group differences in rearing were significant for open-field (ANOVA;
F 5.153; p 0.0178) and hole-board (F 7.731; p 0.0045) tests but not for dark-box
test. In open-field and hole-board tests, rearing count in GABHS mice having serum anti-DCN
immunoreactivity [anti-DCN()] was significantly greater than for control mice and for mice
lacking serum anti-DCN immunoreactivity [anti-DCN()] ( post hoc Fisher’s PLSD; *p 0.03;
**p 0.01; ***p 0.005). Error bars indicate SE.
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profiled individual mouse sera in Western blots of GABHS ho-
mogenate. Sera obtained at the time of Trial 1 were used at dilu-
tions of 1:250 and 1:2500. All 10 GABHS mouse sera were immu-
noreactive with GABHS at dilutions of 1:250 (data not
shown)and 1:2500 (Fig. 7a). Although patterns were not consis-
tent, anti-DCN() sera were more reactive over the entire range
of GABHS proteins than anti-DCN() sera (Fig. 7a; asterisks
correspond to anti-DCN[] sera). Serum from one control
mouse had modest binding to GABHS at 1:250 dilution (data not
shown).
We next examined the relationship between behavior and the
magnitude of the anti-GABHS antibody response to GABHS im-
munization. Z test and Fisher’s r to z transformation were used to
test for correlations of behavioral variables (trial 1 tests) with
serum anti-GABHS immunoreactivity index. Control mice were
not included in this analysis. Serum immunoreactivity to GABHS
was correlated with rearing count in both open-field (r 2 0.648;
p  0.0411) (Fig. 7b) and hole-board (r 2  0.669; p  0.0325)
tests and with move time in open-field (r 2 0.790; p 0.0046)
(Fig. 7c) and hole-board (r 2  0.748; p  0.0103) tests. Other
measures of ambulatory behavior in trial 1 open-field and hole-
board tests correlated with serum immunoreactivity to GABHS
included total distance, average velocity, ambulatory distance,
and average distance per ambulatory movement (Table 2). Serum
anti-GABHS immunoreactivity was not correlated with center
time, behavioral measurements from the dark-box test, or ex-
ploratory nose pokes into the hole board (data not shown).
Within the GABHS-immunized group, there was a correla-
tion between serum anti-GABHS immunoreactivity and ambu-
latory distance: mice that had high serum anti-GABHS immuno-
reactivity were most ambulatory (Fig. 7). However, group
comparisons showed that ambulatory behavior in GABHS-
immunized mice was decreased overall compared with control
mice (Fig. 4) (mean ambulatory distance: GABHS, 1431 cm 
179 SD; controls, 1746 cm 392 SD; range: GABHS, 1214 –1727
cm; controls, 1339 –2452 cm). Together, these results show that,
although ambulatory behavior was decreased in the GABHS
group as a whole, it was lowest in GABHS mice that had low
serum antibody responses to GABHS immunization. When am-
bulatory distance in anti-DCN(), anti-DCN(), and control
groups was compared, ANOVA showed a significant effect of
group, with anti-DCN() group showing the lowest mean am-
bulatory distance [F 2.715; p 0.0393; mean ambulatory dis-
tance (in cm  SD): control vs anti-DCN()  1746  392 vs
1263  41; Fisher’s PLSD, p  0.0130; control vs anti-
DCN()  1746  392 vs 1544  136; Fisher’s PLSD, p  ns;
anti-DCN() vs anti-DCN(); Fisher’s PLSD, p ns].
To identify the antigen in brain tissue containing GABHS
cross-reactive epitopes, normal mouse cerebellum was homoge-
nized and analyzed by Western immunoblot using 10% SDS-
PAGE. No specific immunoreactivity was observed with anti-
DCN() mouse sera (data not shown). To consider the
possibility that conformational epitopes might be implicated, we
next examined proteins extracted under nondenaturing condi-
tions. One GABHS mouse serum was strongly immunoreactive
in dot blot and nondenaturing Western blot analyses (Fig. 8a).
Sera from control CFA:IFA-immunized mice were not reactive.
Nondenaturing immunoprecipitations of normal mouse cere-
bellum were performed using sera from anti-DCN() mouse
immunoreactive in nondenaturing Western blots. After size frac-
tionation on 12% polyacrylamide gels, proteins were excised and
subjected to LC/MS/MS mass spectrometry (Fig. 8b). Two pro-
teins were identified through this analysis: -2-macroglobulin
and C4 complement.
Discussion
A broad spectrum of neuropsychiatric disorders is described in
association with human GABHS infection, including SC, OCD,
TS, and ADHD. Several lines of evidence suggest a role for hu-
moral immunity in these disorders, including the presence of
antineuronal antibodies (Husby et al., 1977; Kiessling et al., 1994;
Singer et al., 1998; Wendlandt et al., 2001), clinical response to
plasmapheresis or IVIg (Perlmutter et al., 1999), association of
the disorder with the B cell marker D8/17 (Swedo et al., 1997),
and the observation that intrastriatal injection of serum or IgG
from subjects with TS elicits tic-like behavior in rats (Hallett et al.,
2000; Taylor et al., 2002).
To investigate the role of immunity in the pathogenesis of
GABHS-associated disease, we established a murine model on the
basis of immunization with GABHS. GABHS mice had behav-
ioral disturbances, serum antibodies that bound to specific brain
regions, and IgG deposits in the brain. Immunolabeling was most
prominent in DCN and colocalized in neuronal cell bodies with
the synaptic marker SNAP-25. Labeling was present to a lesser
degree in the thalamus and globus pallidus, brain regions repre-
senting elements of the CSTC loop thought to mediate PANDAS
symptoms. GABHS mice were less ambulatory than controls;
however, the subset of GABHS mice having serum anti-DCN
antibodies exhibited increased rearing behavior during open-
field and hole-board tests. The overall tendency toward hypoac-
tivity observed in trial 1 in GABHS mice was most prominent in
the subset that had low serum antibody responses to GABHS
immunization. This may reflect differences between GABHS
Table 1. Rearing counts are significantly correlated with other behavioral variables in dark-box, open-field, and hole-board tests
Behavioral variable
Dark box Open field Hole board
Control GABHS Control GABHS Control GABHS
Dark time ns ns
Ambulatory distance r2 0.78 r2 0.62 ns r2 0.68 r2 0.63 r2 0.71
p 0.006 p 0.055 p 0.028 p 0.070 p 0.018
Center time r2 0.620 ns r2 0.86 r2 0.90 ns ns
p 0.0552 p 0.0006 p 0.0001
Nose pokes ns ns
Measurements of several behavioral variables were recorded in dark-box, open-field, and hole-board tests using an automated system (see Materials and Methods). Z-test and Fisher’s r to z transformation (Statview software) were used
to determine significant correlations between rearing count and other behavioral variables. Correlation coefficients (r2) and corresponding p values, where p 0.1, are presented; significant correlations are in bold.
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subsets in postimmunization Th1/Th2 cytokine responses and
their potential modulation of behavior. Rearing and ambulatory
behavior in GABHS-immunized mice were correlated with quan-
titative measures of serum IgG immunoreactivity to Western
blotted GABHS proteins and IgG deposits in the DCN. Although
this study did not establish a causal relationship between serum
anti-DCN antibodies and behavioral abnormalities, our results
support the hypothesis that anti-GABHS antibodies cross-
reactive with brain may contribute to behavioral disturbances
and provide a model system with which to further investigate the
relationship between the immune response to GABHS and neu-
ropsychiatric disorders.
There is precedent for the observation that GABHS elicits
antibodies cross-reactive to host proteins. Cross-reactive mouse
monoclonal GABHS antibodies that bind to cytoskeletal and
basement membrane proteins have been described previously
(Cunningham, 2000). GABHS monoclonal antibodies that cross-
react with N-acetyl--D-glucosamine (GlcNac), a component of
GABHS and host carbohydrate, have also been found. Polyclonal
antisera generated against GABHS proteins were found to be
cross-reactive to unidentified components of human brain tissue
Figure 6. IgG deposits in the DCN are associated with increased rearing behavior. Spear-
man’s rank correlation test was performed to test for significant correlations between rank
scores for DCN IgG deposits and rearing and ambulatory behaviors. Individual scores for behav-
ioral variables were converted to ranked data. a, Rank score for rearing count plotted as a
function of rank score for DCN IgG deposits. b, Rank score for ambulatory distance plotted as a
function of rank score for DCN IgG deposits. Filled boxes denote individual control mice, and
open boxes denote individual GABHS mice. Regression lines were calculated by Statview soft-
ware. For all mice (n 20), Spearman’s rank correlation test showed that rank scores for IgG
deposits were significantly correlated with rank scores for rearing count (Spearman’s Rho
0.477; p 0.0377) but not with rank scores for ambulatory distance. When control individuals
were omitted from the analysis, however, there were significant correlations between rank
scores for IgG deposits and both behavioral variables (rearing count: Spearman’s Rho 0.700,
p 0.0360; ambulatory distance: Spearman’s Rho 0.721, p 0.0305; dotted lines repre-
sent regression lines for GABHS-immunized animals only).
Figure 7. Sera from GABHS mice are immunoreactive to Western blotted GABHS proteins
and correlate with behavior. Immunoblotting was performed on strips cut from Western blots of
GABHS proteins resolved by SDS-PAGE, with sera from GABHS mice used as primary antisera. A
Z test and Fisher’s r to z transformation were used to determine significant correlations between
the magnitude of serum immunoreactivity to GABHS proteins (serum anti-GABHS immuno-
reactivity index; see Materials and Methods) and behavioral measurements. a, GABHS-immune
sera from individual mice (designated G1–G10) at 1:2500 dilution. Asterisks indicate mice with
serum anti-DCN immunoreactivity; individual rank score for DCN IgG deposits are shown below
asterisks. b, c, Rearing count ( b) and move time ( c) from trial 1 open-field tests are plotted as a
function of the serum anti-GABHS immunoreactivity index. Regression lines were calculated by
Statview software. The serum anti-GABHS immunoreactivity index was significantly correlated
with rearing count (r 2  0.648; p  0.0411) and ambulatory distance (r 2  0.790; p 
0.0046). The presence of high serum anti-GABHS immunoreactivity was most often associated
with serum anti-DCN immunoreactivity and a high rank score for IgG deposits in the DCN.
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(Bronze and Dale, 1993). Our results indicate that cross-reactive
antibodies in some GABHS mice bind to sequences found in C4
complement and -2-macroglobulin proteins in the cerebellum
of normal mice. Regions of sequence homology contain thioester
bonds (Isaac and Isenman, 1992) that are associated with func-
tion and sensitive to denaturing conditions (Sim and Sim, 1981,
1983). Deficiency of C4, a member of the -2-macroglobulin
superfamily and a component of the classical pathway of comple-
ment activation, is associated with autoimmunity in mouse mod-
els of systemic lupus erythematosus (Paul et al., 2002) and in
humans with the disease (Traustadottir et al., 2002). C4b also
binds to a region on C4b-binding protein that overlaps with the
binding site for M-proteins, anti-phagocytosis factors of strepto-
coccus. Antibodies to C4 protein generated in GABHS mice
might lead to reduced C4, or C4b function, or dysregulation of
complement pathways, increasing the susceptibility of these mice
to autoimmune disorders. Complement regulation may also play
a role in CNS response to inflammatory signals (Barnum, 2002).
-2-macroglobulin, a large glycoprotein protease inhibitor acti-
vated in brain by monoamines, has complex effects on neurite
growth through interactions with neurotrophins (Mori et al.,
1991; Skornicka et al., 2002). Binding of -2-macroglobulin may
play a role in the pathogenesis of streptococcus-related disease
(Toppel et al., 2003). Whether molecules targeted by cross-
reactive immune responses in GABHS mice are relevant in hu-
man PANDAS remains to be determined.
Anti-GABHS antibodies labeled small structures that resem-
ble synaptic varicosities (Fig. 2). Double-labeling experiments
revealed colocalization of fluorescent signal from GABHS sera
and the synaptic marker SNAP-25 (Fig. 1). The pattern and dis-
tribution of immunolabel for GABHS sera are similar to that
observed using techniques that stain the perineuronal net, a spe-
cialized basement membrane that surrounds neuronal somata in
several brain regions, including the DCN and brainstem nuclei
(Celio and Blumcke, 1994; Seeger et al., 1994). Interestingly, peri-
neuronal nets of the DCN are readily stained using lectins that
bind to GlcNac (Brauer et al., 1984; Steindler and Cooper, 1986).
Given the cross-reactivity of some GABHS antibodies to GlcNac,
and the similarity in distribution of anti-DCN immunoreactivity
and perineuronal nets, we speculate that the GABHS antibodies
cross-reactive to DCN may bind to a glycoprotein associated with
the perineuronal net.
Given the basal ganglia volume changes reported in the
PANDAS subgroup of OCD (Giedd et al., 2000) and the positive
correlation between increased putamen and globus pallidus vol-
umes and serum GABHS antibodies in subjects with OCD and
ADHD (Peterson et al., 2000), we predicted that GABHS mice
would have antibodies cross-reactive with these brain regions.
Some sera from GABHS mice were immunoreactive to globus
pallidus and thalamus; however, the most striking immunoreac-
tivity was to the DCN. In addition, despite the contribution of
cerebellar regions during practicing of well learned motor skills,
especially in the region of the deep cerebellar nuclei (Imamizu et
al., 2000), the contributions of the cerebellum to behavior are not
well recognized. Some PANDAS–OCD–TS imaging studies use
the cerebellum as a reference point, precluding a direct assess-
ment of its contributions, and most studies of immunoreactivity
patterns of sera from OCD, TS, or SC patients have not examined
immunoreactivity against cerebellum. Indeed, one study that in-
cluded an assessment of immunoreactivity of cerebellum and
cortex to streptococcal M-protein found reactivity against both
cerebellum and cortex, although the most intense antibody reac-
tions were observed with sections from basal ganglia (Bronze and
Dale, 1993). Furthermore, several imaging studies that evaluated
cerebellum in OCD (Kim et al., 2001; Kang et al., 2003) or the
OCD spectrum disorder, trichotillomania (Swedo et al., 1991),
report abnormalities in cerebellum at baseline or normalization
Figure 8. GABHS mouse sera binds to -2-macroglobulin and C4 complement in mouse
cerebellum. a, Sera from mice immunized with GABHS were analyzed for binding to mouse
cerebellar proteins in nondenaturing Western blots. b, Serum from a mouse with IgG deposits in
DCN was used to precipitate protein from mouse cerebellum under nondenaturing conditions.
Proteins were fractionated by 10% PAGE and stained with Sypro Ruby. Bands in lane 2 were
excised and analyzed by LC/MS/MS. Lane 1, Control IP with normal mouse sera; lane 2, IP with
GABHS sera. The two bands indicated in lane 2 (arrow) correspond to C4 complement and
-2-macroglobulin.
Table 2. Behavioral variables are significantly correlated with serum anti-GABHS
immunoreactivity
Behavioral variable Open field Hole board
Distance r2 0.75 r2 0.84
p 0.001 p 0.001
Velocity r2 0.76 r2 0.84
p 0.009 p 0.001
Center time ns ns
Ambulatory distance ns r2 0.85
p 0.0008
Average distance– r2 0.64 r2 0.75
ambulatory movement p 0.045 p 0.010
Measurements of several behavioral variables were obtained in open-field and hole-board tests using an automated
system (see Materials and Methods). Z-test and Fisher’s r to z transformation (Statview software) were used to
determine significant correlations between the serum anti-GABHS immunoreactivity index (see Materials and
Methods) and behavioral variables. Correlation coefficients (r2) and corresponding p values are shown.
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in cerebellar regions after treatment. MRI studies have consis-
tently shown decreased volumes in the posterior vermis of sub-
jects with ADHD compared with control subjects (Mostofsky et
al., 1998; Castellanos et al., 2001). Furthermore, children with
autism, many of whom exhibit features of obsessive-compulsive
disorder, have abnormalities in the cerebellum on MRI (Hardan
et al., 2001).
We observed increased parenchymal anti-IgG immunolabel-
ing in the DCN of GABHS mice. Although we interpret this ob-
servation as an indication of IgG accumulation that occurred in
vivo, we cannot rule out the possibility that plasma IgG gained
access to the brain parenchyma postmortem during tissue pro-
cessing. However, the pericapillary distribution of IgG deposits is
consistent with a model wherein anti-DCN antibodies in the pe-
riphery traverse the blood-brain barrier and bind to parenchymal
targets in brain. Although plasma IgG does not typically cross to
the brain, it can do so in the context of changes in the permeabil-
ity of the blood-brain barrier seen in infection, exposure to for-
eign antigens, elevated cytokines or chemokines, or immuniza-
tion with CFA and IFA (Rabchevsky et al., 1999; Chaudhuri,
2000). Additional support for a peripheral source of the IgG de-
posits comes from the lack of increase in the number of cells
labeled with the panimmune cell marker CD45, although it is
possible that immune cell infiltration was present at earlier time
points and had resolved by the time of killing. The observation
that IgG deposits were significantly correlated with altered be-
havior suggests the hypothesis that anti-DCN antibodies may be
implicated in their pathogenesis, perhaps through activation of
complement. Behavioral disturbances and local changes in
catacholaminergic activity have been observed in rats after the
introduction of immune complexes or the anaphylatoxin C5a
into the hypothalamus (Schupf and Williams, 1985; Williams
et al., 1985). Alternatively, binding of anti-brain antibodies to
their target could directly interrupt the function of the target
protein.
Behavioral alterations in GABHS mice varied according to the
profile of the immune response to GABHS. Increased rearing
behavior was associated with increased serum anti-DCN and
anti-GABHS immunoreactivity and IgG deposits in the brain,
whereas GABHS mice having lower serum anti-GABHS immu-
noreactivity were less ambulatory. We propose three potential
explanations for these results. (1) Antibodies to GABHS antigens
cross-react in a dose-dependent manner with neurotransmitter
systems that modulate rearing behavior. Examples from other
disorders in which cross-reactive antibodies are implicated in-
clude Rasmussen’s encephalitis and stiff-person syndrome (Rog-
ers et al., 1994; Whitney et al., 1999; Dalakas et al., 2000). (2) A
robust antibody response to GABHS indicates bias toward a cy-
tokine profile with physiological correlates that influence behav-
ior. We do not have data on cytokine expression profiles in the
GABHS model; however, there is precedent for cytokine-driven
behavioral disturbances in mice (Zalcman et al., 1998; Zalcman,
2001, 2002), wherein peripheral administration of IL-1 caused
reductions in locomotion and exploration of a novel open field,
and IL-2 and IL-6 promoted increased exploration, rearing, and
locomotion. (3) Increased rearing behavior may be a correlate of
an underlying genetic predisposition to specific immune re-
sponses to antigenic challenges. This last model is consistent with
the reported increased frequency of previous diagnoses of neuro-
psychiatric disorders in subjects with acute RF (Mercadante et al.,
2000).
Rearing in mice is considered to be a component of spatial
orientation and exploration of novel surroundings. It is typically
inhibited by anxiogenic circumstances and is modulated by
monoaminergic systems. In novel surroundings, when there is
motivation to return to the home cage, rearing presumably facil-
itates spatial orientation through improved visual and olfactory
surveillance. Rearing is decreased by depleting brain dopamine
(Hofele et al., 2001) and with benzodiazepines or 5-HT1A ago-
nists (Tsuji et al., 2000). Rearing is increased by-2 adrenorecep-
tor antagonists (Delini-Stula, 1984) and dopamine D2 receptor
agonists (Starr and Starr, 1986). In our study, increased rearing in
control and GABHS mice was highly correlated with increased
center time in open field and, to a lesser extent, with increased
ambulation (Table 1). Rearing was not positively correlated with
behaviors associated with increased anxiety, such as time spent in
dark box, or thigmotaxis. Thus, increased rearing in GABHS
mice may indicate a generalized behavioral disinhibition, in
which exploratory behaviors normally expressed in response to a
novel environment are facilitated. In mice with serum anti-DCN
antibodies, however, rearing was increased independently of am-
bulatory distance and center time. This finding is consistent with
rearing serving as an index to repetitive or compulsive rather than
exploratory behavior.
We found significant correlations between measures for se-
rum immunoreactivity to GABHS proteins, rearing count, and
ambulatory behavior. The correlation in GABHS mice between
IgG response to GABHS antigens and specific behaviors is in-
triguing in light of findings in human subjects with disorders
associated with GABHS. Increased serum titers of antibodies to
GABHS were associated with ADHD (Peterson et al., 2000) and
TS (Muller et al., 2000, 2001). In GABHS mice, increased rearing
behavior may reflect deficits in attention and disinhibited behav-
ior similar to that seen in ADHD and TS.
Despite compelling similarities between the GABHS mouse
and the human diseases it was designed to model, there are im-
portant caveats. Mice are not natural hosts for GABHS; thus,
their immune response to GABHS antigens may differ from hu-
mans. Similarly, functional responses to brain injury may differ
in mice and humans. Last, our mouse model is based on experi-
mental immunization rather than natural infection. These differ-
ences notwithstanding, this model provides a starting point for
investigations of the pathophysiology underlying motor and be-
havioral disturbances sometimes associated with an immune re-
sponse to GABHS.
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